Skip to main content
TipRanks
Go Ultimate75% OFF

Humana (HUM) Stock Price & Analysis

2,766 Followers

HUM Stock Chart & Stats

$390.00$10.00(2.63%)
At close: 4:00 PM EST
$375$400$425$450Aug 24Sep 8Sep 21Oct 5Oct 19Nov 2Nov 16
Day’s Range
$387.83 - $401.98
52-Week Range
$163.11 - $462.87
Previous Close
$380.00
Volume
N/A
Average Volume (3M)
1.67M
Market Cap
$46.84B
Enterprise Value
$59.05B
Total Cash (Recent Filing)
$25.11B
Total Debt (Recent Filing)
$12.50B
Price to Earnings (P/E)
37.6
Beta
1.02
Next Earnings
Feb 10, 2027 (Est.)
Dividend Yield
0.91%

Bulls Say, Bears Say

Bulls Say

Strong Revenue Growth

Humana has continued expanding its revenue base despite slower growth than in earlier years. This scale reflects durable demand for Medicare-focused insurance and healthcare services, giving the company a broader membership and premium platform from which operating improvements can compound.

Medicare Advantage Quality Strength

Exceptional Stars performance strengthens Humana’s competitive position in Medicare Advantage because quality ratings influence bonus economics and enrollment appeal. A high share of members in 4+ Star plans can support revenue potential, product competitiveness, and future margin recovery.

CenterWell And Medicaid Expansion

Growth across CenterWell primary care and Medicaid broadens Humana beyond its established insurance base and increases exposure to care delivery and dual-eligible opportunities. The expansion also supports care coordination capabilities that can improve outcomes and manage total medical costs.

Bears Say

Material Profitability Compression

The sharp decline in net, EBIT, and EBITDA margins shows that revenue growth has not translated proportionally into earnings. Persistently lower profitability reduces internal funding capacity, weakens returns on equity, and leaves less room to absorb medical-cost pressure or execution setbacks.

Higher Medical And Pharmacy Cost Trends

Rising cost trends create a structural pressure on insurance margins because Humana must price benefits and manage care ahead of claims development. The especially high Part D outlook could raise pharmacy-related expenses and make the planned 2027 margin improvement more execution-dependent.

Volatile Cash Generation

The wide swings in operating and free cash flow make cash conversion less predictable than the revenue trajectory. Although TTM cash flow improved, inconsistent working-capital effects and an anomalous cash-flow-to-earnings relationship can constrain confidence in funding growth, debt actions, and shareholder returns.

Humana News

HUM FAQ

What was Humana’s price range in the past 12 months?
Humana lowest stock price was $163.11 and its highest was $462.87 in the past 12 months.
What is Humana’s market cap?
Humana’s market cap is $46.84B.
When is Humana’s upcoming earnings report date?
Humana’s next earnings report is estimated for Feb 10, 2027 (not yet confirmed), which is in 80 days.
How were Humana’s earnings last quarter?
Humana released its earnings results on Nov 06, 2026. The company reported -$0.7 earnings per share for the quarter, beating the consensus estimate of -$1.001 by $0.301.
Is Humana overvalued?
According to Wall Street analysts Humana’s price is currently Undervalued.
Does Humana pay dividends?
Humana pays a quarterly dividend of $0.885 which represents an annual dividend yield of 0.91%. See more information on Humana dividends here
What is Humana’s EPS estimate?
Humana’s EPS estimate is -7.58.
How many shares outstanding does Humana have?
Humana has 120,103,250 shares outstanding.
What happened to Humana’s price movement after its last earnings report?
Humana reported an EPS of -$0.7 in its last earnings report, beating expectations of -$1.001. Following the earnings report the stock price went up 5.33%.
Which hedge fund is a major shareholder of Humana?
Hedge funds hold Humana shares: the largest hedge-fund position in Humana is 72,325,316 shares, and hedge funds decreased their holdings by 2.7M shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology